Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Coronary Syndrome | 10 | 2023 | 2337 | 1.560 |
Why?
|
Secondary Prevention | 4 | 2023 | 1530 | 0.850 |
Why?
|
Benzamides | 8 | 2019 | 1379 | 0.830 |
Why?
|
Lipoproteins, HDL | 6 | 2023 | 638 | 0.800 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 290 | 0.720 |
Why?
|
Apolipoprotein A-I | 6 | 2023 | 281 | 0.720 |
Why?
|
Enoxaparin | 7 | 2019 | 377 | 0.720 |
Why?
|
Anticoagulants | 9 | 2021 | 4599 | 0.660 |
Why?
|
Thrombolytic Therapy | 2 | 2018 | 2161 | 0.650 |
Why?
|
Angioplasty, Balloon | 1 | 2022 | 653 | 0.640 |
Why?
|
Coronary Circulation | 1 | 2024 | 1572 | 0.620 |
Why?
|
Venous Thromboembolism | 8 | 2018 | 1671 | 0.610 |
Why?
|
Pyridines | 9 | 2019 | 2825 | 0.550 |
Why?
|
Collateral Circulation | 1 | 2017 | 287 | 0.540 |
Why?
|
Venous Thrombosis | 5 | 2018 | 1239 | 0.520 |
Why?
|
Students, Nursing | 1 | 2015 | 45 | 0.500 |
Why?
|
Education, Nursing | 1 | 2015 | 82 | 0.490 |
Why?
|
Plaque, Atherosclerotic | 2 | 2023 | 1519 | 0.490 |
Why?
|
Troponin | 1 | 2017 | 524 | 0.470 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11727 | 0.440 |
Why?
|
Carotid Arteries | 1 | 2016 | 952 | 0.400 |
Why?
|
Renal Dialysis | 3 | 2017 | 1786 | 0.380 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2021 | 3068 | 0.360 |
Why?
|
Education, Medical, Undergraduate | 2 | 2016 | 1008 | 0.350 |
Why?
|
Pulmonary Embolism | 3 | 2017 | 2376 | 0.340 |
Why?
|
Vitamin K 2 | 2 | 2019 | 47 | 0.330 |
Why?
|
Hemorrhage | 8 | 2021 | 3461 | 0.320 |
Why?
|
Acute Disease | 5 | 2017 | 7149 | 0.320 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 5034 | 0.310 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 2158 | 0.300 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.290 |
Why?
|
Tissue and Organ Procurement | 1 | 2015 | 896 | 0.290 |
Why?
|
Thrombosis | 2 | 2017 | 2968 | 0.280 |
Why?
|
Students, Medical | 2 | 2016 | 1862 | 0.260 |
Why?
|
Cholesterol | 6 | 2023 | 2917 | 0.250 |
Why?
|
Double-Blind Method | 11 | 2022 | 12026 | 0.250 |
Why?
|
Patient Readmission | 1 | 2018 | 3114 | 0.240 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6487 | 0.240 |
Why?
|
Treatment Outcome | 16 | 2024 | 63114 | 0.240 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3610 | 0.220 |
Why?
|
Cardiovascular Diseases | 6 | 2021 | 15165 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3843 | 0.210 |
Why?
|
Coronary Angiography | 2 | 2024 | 4577 | 0.210 |
Why?
|
Vascular Resistance | 1 | 2024 | 936 | 0.190 |
Why?
|
Coated Materials, Biocompatible | 1 | 2022 | 319 | 0.190 |
Why?
|
Humans | 51 | 2024 | 744343 | 0.190 |
Why?
|
Vitamin K | 3 | 2017 | 295 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.180 |
Why?
|
Heart Failure | 3 | 2018 | 10900 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2018 | 10943 | 0.180 |
Why?
|
Drug Therapy, Combination | 3 | 2018 | 6489 | 0.170 |
Why?
|
Microcirculation | 1 | 2024 | 1286 | 0.170 |
Why?
|
Vascular Diseases | 2 | 2017 | 1161 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 246 | 0.160 |
Why?
|
Extracellular Matrix Proteins | 2 | 2019 | 849 | 0.160 |
Why?
|
Vitamin K Deficiency | 1 | 2017 | 24 | 0.150 |
Why?
|
Cost-Benefit Analysis | 2 | 2024 | 5391 | 0.150 |
Why?
|
Calcium-Binding Proteins | 2 | 2019 | 1081 | 0.150 |
Why?
|
Education | 1 | 2020 | 543 | 0.150 |
Why?
|
International Normalized Ratio | 1 | 2018 | 367 | 0.140 |
Why?
|
Antidotes | 1 | 2017 | 138 | 0.140 |
Why?
|
Ondansetron | 1 | 2017 | 90 | 0.140 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2017 | 119 | 0.140 |
Why?
|
Kidney Failure, Chronic | 3 | 2018 | 2538 | 0.140 |
Why?
|
Factor Xa | 1 | 2017 | 162 | 0.140 |
Why?
|
Multilingualism | 1 | 2016 | 87 | 0.140 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2016 | 45 | 0.140 |
Why?
|
Atherosclerosis | 2 | 2022 | 3445 | 0.130 |
Why?
|
Kidney Tubules | 1 | 2018 | 488 | 0.130 |
Why?
|
Creatine Kinase, MB Form | 1 | 2016 | 214 | 0.130 |
Why?
|
Haloperidol | 1 | 2017 | 397 | 0.130 |
Why?
|
Antiemetics | 1 | 2017 | 177 | 0.130 |
Why?
|
Paclitaxel | 1 | 2022 | 1708 | 0.130 |
Why?
|
Kidney Glomerulus | 1 | 2018 | 697 | 0.130 |
Why?
|
Oligopeptides | 2 | 2016 | 1189 | 0.120 |
Why?
|
Drug Administration Schedule | 3 | 2017 | 4933 | 0.120 |
Why?
|
Nurse's Role | 1 | 2015 | 209 | 0.110 |
Why?
|
Medical History Taking | 1 | 2016 | 783 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 966 | 0.110 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 426 | 0.110 |
Why?
|
Transplants | 1 | 2015 | 209 | 0.110 |
Why?
|
Coronary Vessels | 1 | 2024 | 3107 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2018 | 956 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2017 | 544 | 0.100 |
Why?
|
Troponin I | 1 | 2016 | 619 | 0.100 |
Why?
|
Stroke | 4 | 2019 | 9981 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1076 | 0.100 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.100 |
Why?
|
Kidney Transplantation | 2 | 2017 | 4251 | 0.100 |
Why?
|
Risk Assessment | 4 | 2022 | 23338 | 0.090 |
Why?
|
Male | 25 | 2019 | 350118 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1496 | 0.090 |
Why?
|
Administration, Oral | 1 | 2017 | 3913 | 0.090 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 984 | 0.090 |
Why?
|
Anemia, Sickle Cell | 1 | 2018 | 1018 | 0.090 |
Why?
|
Anesthesia, General | 1 | 2017 | 1171 | 0.090 |
Why?
|
Female | 25 | 2019 | 380194 | 0.090 |
Why?
|
Aged | 16 | 2018 | 163280 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6538 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1573 | 0.090 |
Why?
|
Risk Factors | 7 | 2022 | 72290 | 0.090 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1917 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39050 | 0.080 |
Why?
|
Cardiology | 1 | 2020 | 1668 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1622 | 0.080 |
Why?
|
Hospitalization | 5 | 2021 | 10262 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1663 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3584 | 0.080 |
Why?
|
Physician's Role | 1 | 2015 | 943 | 0.080 |
Why?
|
Stents | 2 | 2016 | 3280 | 0.080 |
Why?
|
Drug Costs | 1 | 2015 | 1105 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2019 | 1620 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6622 | 0.070 |
Why?
|
Intention to Treat Analysis | 2 | 2018 | 426 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2018 | 2149 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6459 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1390 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1972 | 0.070 |
Why?
|
Prospective Studies | 4 | 2018 | 53288 | 0.070 |
Why?
|
Tissue Donors | 1 | 2015 | 2240 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1814 | 0.060 |
Why?
|
Glomerular Filtration Rate | 3 | 2018 | 2170 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5097 | 0.060 |
Why?
|
Societies, Medical | 1 | 2017 | 3743 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2208 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9959 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2016 | 3821 | 0.060 |
Why?
|
Middle Aged | 11 | 2018 | 213383 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12354 | 0.050 |
Why?
|
Kidney | 2 | 2016 | 7186 | 0.050 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2356 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Creatinine | 2 | 2018 | 1919 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3605 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.050 |
Why?
|
Phosphatidylcholines | 1 | 2022 | 411 | 0.050 |
Why?
|
Apolipoproteins B | 1 | 2022 | 374 | 0.050 |
Why?
|
Adult | 10 | 2019 | 214055 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2018 | 112 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 841 | 0.040 |
Why?
|
Biological Transport | 1 | 2022 | 2118 | 0.040 |
Why?
|
Migraine with Aura | 1 | 2019 | 203 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 866 | 0.040 |
Why?
|
Western World | 1 | 2016 | 27 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 559 | 0.040 |
Why?
|
United States | 3 | 2020 | 69872 | 0.040 |
Why?
|
Hydroxyurea | 1 | 2018 | 290 | 0.040 |
Why?
|
Hematuria | 1 | 2018 | 235 | 0.040 |
Why?
|
Lebanon | 1 | 2016 | 229 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 257 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
Half-Life | 1 | 2016 | 661 | 0.030 |
Why?
|
Sample Size | 1 | 2018 | 845 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10252 | 0.030 |
Why?
|
Bilirubin | 1 | 2016 | 425 | 0.030 |
Why?
|
Chick Embryo | 1 | 2016 | 982 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2016 | 592 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2454 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
Lactones | 1 | 2016 | 329 | 0.030 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2016 | 361 | 0.030 |
Why?
|
Research Design | 2 | 2022 | 5987 | 0.030 |
Why?
|
Electrocardiography | 2 | 2017 | 6442 | 0.030 |
Why?
|
Placebo Effect | 1 | 2016 | 502 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2018 | 57776 | 0.030 |
Why?
|
Medication Adherence | 1 | 2023 | 2063 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 855 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2274 | 0.020 |
Why?
|
Medical Records | 1 | 2017 | 1413 | 0.020 |
Why?
|
Comprehension | 1 | 2016 | 610 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2017 | 1127 | 0.020 |
Why?
|
Clinical Clerkship | 1 | 2016 | 532 | 0.020 |
Why?
|
Analgesics | 1 | 2018 | 1040 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2971 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 738 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
Angiography | 1 | 2016 | 1639 | 0.020 |
Why?
|
Primary Prevention | 1 | 2017 | 1167 | 0.020 |
Why?
|
Schools, Medical | 1 | 2016 | 880 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2016 | 753 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 25043 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2518 | 0.020 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2017 | 3297 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4776 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Graft Rejection | 1 | 2015 | 4397 | 0.010 |
Why?
|
Blood Pressure | 1 | 2017 | 8554 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56430 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7474 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15226 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15076 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 8987 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18370 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8480 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168757 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_